We are live on
!
Find out more
MWM
Minot Wealth Management Portfolio holdings
AUM
$389M
1-Year Est. Return
3.39%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
-3.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$69.7M
(+26%)
Cap. Flow
+$45.6M
Cap. Flow
% of AUM
13.6%
Top 10 Holdings %
Top 10 Hldgs %
29.22%
Holding
167
New
25
Increased
77
Reduced
29
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IQ MacKay Municipal Insured ETF
MMIN
|
+$14.5M |
| 2 |
Innovative Industrial Properties
IIPR
|
+$2.52M |
| 3 |
Vroom Inc
VRM
|
+$2.42M |
| 4 |
CrowdStrike
CRWD
|
+$2.17M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$1.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.3M |
| 2 |
Gilead Sciences
GILD
|
+$2.23M |
| 3 |
Amgen
AMGN
|
+$1.89M |
| 4 |
American Tower
AMT
|
+$1.89M |
| 5 |
Intel
INTC
|
+$1.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.87% |
| 2 | Miscellaneous | 20% |
| 3 | Healthcare | 15.74% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Financials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
X4 Pharmaceuticals
XFOR
$401M
| $151K | 0.05% |
+784
| New | +$154K |
|
152
Cohen & Steers Quality Income Realty Fund
RQI
$1.66B
| $149K | 0.04% |
12,000
| – | – |
|
153
PDS Biotechnology
PDSB
$11.8M
| $105K | 0.03% |
+49,203
| New | +$108K |
|
|
AGEN
154
Agenus
AGEN
$345M
| $32K | 0.01% |
509
| – | – |
|
|
REED
155
DELISTED
Reeds, Inc. Common Stock
REED
| $30K | 0.01% |
1,000
| – | – |
|
156
Arista Networks
ANET
$246B
| – | – |
-120,000
| Closed | -$1.55M |
|
157
AstraZeneca
AZN
$252B
| – | – |
-12,773
| Closed | -$1.4M |
|
|
158
Gilead Sciences
GILD
$181B
| – | – |
-35,210
| Closed | -$2.23M |
|
159
GSK
GSK
$102B
| – | – |
-8,200
| Closed | -$386K |
|
|
160
Eli Lilly
LLY
$1.05T
| – | – |
-15,553
| Closed | -$2.3M |
|
161
CALL
Norwegian Cruise Line
NCLH
$7.65B
| – | – |
-10,000
| Closed | -$21K |
|
162
Regeneron Pharmaceuticals
REGN
$81.8B
| – | – |
-3,050
| Closed | -$1.71M |
|
163
Sanofi
SNY
$107B
| – | – |
-19,589
| Closed | -$983K |
|
|
USAS
164
Americas Gold and Silver
USAS
$1.84B
| – | – |
-11,394
| Closed | -$75K |
|
Similar funds
CP
BWM
FPS
IC
TF
RIM
PPW
HA
Minot Wealth Management's Q4 2020 Portfolio in Review
As of Q4 2020, Minot Wealth Management held 167 positions worth $335M, up 26% from $265M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Minot Wealth Management deployed $45.6M of net new capital in Q4 2020, opening 25 new positions and adding to 77 existing holdings. Its largest new stake was Innovative Industrial Properties: 16,807 shares worth $3.08M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $1.89M trimmed.
- Minot Wealth Management's largest Q4 2020 buy was Innovative Industrial Properties: 16,807 shares worth $3.08M.
- Minot Wealth Management added most to IQ MacKay Municipal Insured ETF in Q4 2020, an estimated $14.5M increase.
- Minot Wealth Management's biggest Q4 2020 reduction was Amgen, cutting an estimated $1.89M.
- Minot Wealth Management fully exited Eli Lilly in Q4 2020, selling an estimated $2.3M.
- Minot Wealth Management's ten largest holdings make up 29% of its $335M portfolio in Q4 2020.
- Minot Wealth Management opened 25 new positions and closed 9 in Q4 2020.
- Minot Wealth Management's portfolio value rose 26% quarter-over-quarter to $335M.
Based on Minot Wealth Management's 13F filing for Q4 2020, filed 28 Jan 2021.